Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Intact casein is the primary, naturally structured protein found in milk and dairy products. It is characterized as a 'slow-digesting' protein because it forms a gel or clot (micellar structure) in the acidic environment of the stomach. This property delays gastric emptying and results in a gradual, sustained release of amino acids into the bloodstream over several hours. Due to its slow absorption kinetics, intact casein is investigated for its potential health benefits, including enhancing satiety, reducing overall food intake, and modulating metabolic rate, which may aid in weight management and obesity prevention. It is often contrasted in clinical studies with 'fast-digesting' proteins like whey and hydrolyzed casein to understand how protein absorption speed influences muscle protein synthesis, appetite-regulating hormones (e.g., GLP-1), and substrate oxidation. Research has also explored its role in mitigating age-related muscle loss (sarcopenia) and its effects on metabolic health in individuals with obesity or metabolic syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on intact casein.